BioNexus Gene Lab (BGLC): Q3 Revenue Fell 98.12% as Trading at Chemrex Nearly Stopped
22 hours ago
BioNexus Gene Lab reported a 98.12% drop in Q3 revenue for its Chemrex unit, resulting in a $1.88 million net loss. Auditors have expressed substantial doubt about the company's ability to continue as a going concern within the next year.
2026-05-12
BioNexus Gene Lab Corp (BGLC)2026-07-26
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings2026-07-27
BioNexus Gene Lab Corp (BGLC) Cash FlowShow all 21 updates